Alternatives to Baccine

Biopharmaceutical company developing mRNA-based vaccines and therapeutics for infectious diseases and cancer.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

Biotechnology company developing potentially curative cell therapies for cancer patients.

Biotech company developing next-generation immunotherapy agents to unlock the immune system.

Pioneering precision microbiome therapeutics for oncology using CRISPR and synthetic biology.

OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability.

Biomica is developing a novel microbiome-based platform for the treatment of cancer.

Clinical-stage oncology company developing small molecule therapeutics for rare tumors and aggressive cancers.

Develops a novel method to predict patient response to immune checkpoint inhibitors in oncology.

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

Biopharmaceutical company developing targeted neutrophil nanoparticle platform for chronic diseases.

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

Developing topical treatments to prevent and treat skin toxicities from cancer therapies.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

Develops a platform for adaptive clinical trial design and closed-loop execution.

Biotechnology company developing novel therapies for multiple myeloma.

AI-powered blood test for early cancer detection and subtyping.

Omnix Medical is developing a novel platform for advanced wound care management.

Biopharmaceutical company developing innovative punctal plug technology for eye disease therapies.

Developing exosome-based cancer therapeutics using AI and novel human cancer models.

Developing novel therapeutics targeting the tumor microenvironment for cancer treatment.

Revolutionizing prenatal testing with non-invasive fetal DNA analysis from maternal blood.

Genocure AI is developing AI-powered solutions for oncology drug discovery and development.

Cloud-based platform for reproducible computational research in life sciences.

Biopharmaceutical company developing human haploid stem cells for regenerative medicine and disease therapy.

Developing a novel small molecule inhibitor for ovarian cancer treatment targeting DIO3.

Omec.ai is a life sciences startup focused on accelerating drug discovery and development through AI.

Biotech developing novel technologies to restore physiological balance in apoptosis-related diseases.

Leveraging proteomics and machine learning for improved immunotherapy decisions and drug discovery.

Developing engineered biologics to harness the immune system for disease treatment.

Developing novel therapeutic approaches for ocular diseases.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

Develops and launches Padeliporfin VTP therapy for solid tumor treatment.

Drug discovery and development company using a novel technological approach.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

Clinical-stage biotech developing novel therapeutics for hematological malignancies and disorders.

Microbiome drug discovery company developing customized phage therapies for chronic diseases.

Biotechnology company developing novel immunotherapies for cancer.

Developing novel immunotherapies for autoimmune diseases and life-threatening allergies.

Developing novel diagnostics to predict patient response to immunotherapy.

Early-stage clinical company developing smart targeted radioligands for precision oncology.

Immunotherapy company targeting oncology and autoimmune diseases.

Developing microbiome-based therapeutics to address underlying disease biology, particularly in gastrointestinal health.

Clinical-stage immunotherapy company developing novel treatments for cancer.

Clinical-stage biotechnology company developing allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.

Develops and commercializes a novel cancer treatment technology called Alpha DaRT.

CBX Therapeutics is a biotechnology company focused on developing novel therapies for cancer.

A commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases.

AI-driven digital twin of embryo development for cell-based therapies.

Genomic and data science company developing novel drugs based on natural resistance mechanisms.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

Developing a novel therapeutic approach for neurological disorders using advanced neuroimaging and AI.

Developing universal donor-free red blood cells for life-saving transfusions and advanced therapies.

Biotech company developing a novel drug delivery platform using cell membrane-derived nanoparticles.

Designs proteins with superior properties using computational analysis, evolutionary insights, and AI.

Computational platform using LLMs trained on biological and chemical data for drug discovery.

AI-driven platform for protein-level disease mapping and drug discovery.

Own Chemex.ai today. Secure checkout and guided transfer support. No hidden fees.